Funda Şimşek, The Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases*, Gökmen Zararsız, Faruk Karakeçili, Sami Kınıklı, Hüseyin Bilgin, Nesrin Türker, et al. 2020. “Real-World Efficacy, Safety, and Clinical Outcomes of Ombitasvir Paritaprevir Ritonavir ± Dasabuvir ± Ribavirin Combination Therapy in Patients With Hepatitis C Virus Genotype 1 or 4 Infection: The Turkey Experience Experience”. Turkish Journal of Gastroenterology 31 (4):305-17. https://tjg.avesjournals.com/index.php/tjg/article/view/3881.